287 filings
Page 2 of 15
6-K
of9o6vruq vcu
21 Sep 12
YM BioSciences Reports Fiscal 2012 Operational and Financial Results
12:00am
6-K
tsjhqb
14 May 12
Current report (foreign)
12:00am
6-K
dahh60h
11 May 12
Report of Foreign Issuer
12:00am
6-K
i45nqojikxcyfijvd lj
2 Mar 12
Current report (foreign)
12:00am
6-K
qkctbb w10
29 Feb 12
YM BioSciences Raises US$80.5 Million from Public Offering
12:00am
6-K
kro6q8
24 Feb 12
YM BioSciences Prices $70 Million Public Offering of Common Shares
12:00am
6-K
6rcw7k42swh
24 Feb 12
YM BioSciences Announces Proposed Public Offering of Common Shares
12:00am
6-K
q679p0sgozhhzjs0hei0
24 Feb 12
Current report (foreign)
12:00am
6-K
ojfmg e7g
9 Feb 12
Current report (foreign)
12:00am
6-K
e4l2ga6g8 stt8nmi
9 Feb 12
YM BioSciences Reports Operational and Financial Results for the Second Quarter of Fiscal 2012
12:00am
6-K
o9djuvv3
12 Dec 11
YM BioSciences Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASH 2011
12:00am
6-K
om1ut h9xs3bwvk
23 Nov 11
Current report (foreign)
12:00am
6-K
tlsghm l65il2gc7
14 Nov 11
Current report (foreign)
12:00am
6-K
utmxsmbmpzxk z5t5
14 Nov 11
YM BioSciences Reports Operational and Financial Results for the First Quarter of Fiscal 2012
12:00am
6-K
vozxziju27wfl4l ab
7 Nov 11
YM BioSciences to Report Updated Phase I/II Data for CYT387 at ASH 2011
12:00am
6-K
vyw0q4p
31 Oct 11
YM BioSciences Nimotuzumab Results Reported at SIOP Conference
12:00am
6-K
sfupbfq8ul1e98
28 Oct 11
Current report (foreign)
12:00am
6-K
pgwceq0f7q3b2s3oj
19 Oct 11
YM BioSciences Proposes Dr. Catherine Mackey and Dr. Nicole Onetto for Nomination to Board of Directors
12:00am
6-K
ogxkgbatpg68luyyvh
28 Sep 11
Current report (foreign)
12:00am
6-K
4tb7exrrqc9il7ey6rz
26 Sep 11
Current report (foreign)
12:00am